Breast Cancer Research and Treatment

, Volume 40, Issue 1, pp 11–24 | Cite as

Breast cancer in African American women: Epidemiology and tumor biology

  • Bruce J. Trock
Guest editor's introduction


This review of published data on the epidemiology, pathology, and molecular biology of breast cancer in African American women seeks to identify how the etiology and presentation of the disease differ from those in white women. The crossover from higher to lower age-specific incidence rates in African American women at age 45 cannot be explained by current data on the distribution of risk factors. Data from six case-control studies suggest that the relative risks associated with both established and probable breast cancer risk factors are similar in African American and white women. Lower survival in African American compared to white women is primarily attributable to diagnosis at a later stage. However, evidence from a number of studies suggests that tumors in African American women may exhibit a more aggressive phenotype, which could also contribute to the survival disparity. Tumors in African American women are more likely to occur at a younger age, to be poorly differentiated and estrogen receptor negative, and to exhibit high grade nuclear atypia, more aggressive histology (more medullary and less lobular), and higher S-phase. Overexpression of p53 and erbB-2 occurs with similar frequency in African American and white women, although limited data suggest the former may exhibit different p53 mutation spectra. One study found high risk associated with a specific CYP1A1 polymorphism in African American but not white women. Additional studies of molecular differences in African American and white women are needed, with multifactorial assessment of the independent effects of molecular and conventional risk attributes.

Key words

risk factors molecular markers estrogen receptor p53 erbB-2 CYP1A1 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Miller BA, Ries LAG, et al: SEER Cancer Statistics Review 1973–1990. NIH Publication No. 93-2789, U.S. Department of Health and Human Services, Bethesda, 1993Google Scholar
  2. 2.
    Gray GE, Henderson BE, Pike MC: Changing ratio of breast cancer incidence rates with age of black females compared with white females in the United States. J Natl Cancer Inst 64:461–463, 1980PubMedGoogle Scholar
  3. 3.
    Horm JW, Asire AJ, et al: SEER Program: Cancer Incidence and Mortality in the United States 1973–81. NIH Publication No. 85-1837, U.S. Department of Health and Human Services, Bethesda, 1984Google Scholar
  4. 4.
    Pickle LW, Mason TJ, et al: Atlas of U.S. cancer mortality among whites: 1950–1980. USDHHS Publication No. (NIH) 87-2900, Washington, 1987Google Scholar
  5. 5.
    Pickle LW, Mason TJ, et al: Atlas of U.S. cancer mortality among nonwhites: 1950–1980. USDHHS Publication No. (NIH) 90-1582, Washington, 1990Google Scholar
  6. 6.
    Sondik EJ, Edwards BK, et al: Cancer Statistics Review 1973–1986. NIH Publication No. 89-2789, U.S. Department of Health and Human Services, Bethesda, 1989Google Scholar
  7. 7.
    Ries LAG, Miller BA, et al: SEER Cancer Statistics Review 1973–1991. NIH Publication No. 94-2789, U.S. Department of Health and Human Services, Bethesda, 1994Google Scholar
  8. 8.
    Feuer EJ, Wun LM, et al: The lifetime risk of developing breast cancer. J Natl Cancer Inst 85:892–897, 1993PubMedGoogle Scholar
  9. 9.
    Devesa SS, Diamond EL: Association of breast cancer and cervical cancer incidence with income and education among whites and blacks. J Natl Cancer Inst 65:515–528, 1980PubMedGoogle Scholar
  10. 10.
    Austin H, Cole P, Wynder E: Breast cancer in black american women. Int J Cancer 24:541–544, 1979PubMedGoogle Scholar
  11. 11.
    Schatzkin A, Palmer JR, et al: Risk factors for breast cancer in black women. J Natl Cancer Inst 78:213–217, 1987PubMedGoogle Scholar
  12. 12.
    Laing AE, Demenais FM, Williams R, et al: Breast cancer risk factors in African-American women: The Howard University tumor registry experience. J Natl Med Assoc 85:931–939, 1993PubMedGoogle Scholar
  13. 13.
    Mayberry R, Stoddard-Wright C: Breast cancer risk factors among black women and white women: similarities and differences. Am J Epidemiol 136: 1445–1456, 1992PubMedGoogle Scholar
  14. 14.
    Palmer J, Richard L, Harlap S, et al: Adult height and risk of breast cancer among US black women. Am J Epidemiol 141:845–849, 1995PubMedGoogle Scholar
  15. 15.
    Kelsey JL, Gammon MD, John EM: Reproductive factors and breast cancer. Epidemiol Rev 15:36–47, 1993PubMedGoogle Scholar
  16. 16.
    Helmrich SP, Shapiro S, et al: Risk factors for breast cancer. Am J Epidemiol 117:35–45, 1983PubMedGoogle Scholar
  17. 17.
    Stavraky K, Emmons S: Breast cancer in premenopausal and postmenopausal women. J Natl Cancer Inst 53:647–654, 1974PubMedGoogle Scholar
  18. 18.
    Paffenbarger RS, Kampert JB, Chang HG: Characteristics that predict risk of breast cancer before and after menopause. Am J Epidemiol 112:258–268, 1980PubMedGoogle Scholar
  19. 19.
    Bodian CA: Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol Rev 15:177–187, 1993PubMedGoogle Scholar
  20. 20.
    Kelsey JL: Breast cancer epidemiology: summary and future directions. Epidemiol Rev 15:256–263, 1993PubMedGoogle Scholar
  21. 21.
    Willett WC, Browne ML, et al: Relative weight and risk of breast cancer among premenopausal women. Am J Epidemiol 122:731–740, 1985PubMedGoogle Scholar
  22. 22.
    Newcomb PA, Storer BE, et al: Lactation and a reduced risk of premenopausal breast cancer. New Engl J Med 330:81–87, 1994PubMedGoogle Scholar
  23. 23.
    National Center for Health Statistics. Health and Nutritional Examination Survey I: epidemiologic follow-up study wave 1, 1982–1984. Vital Health Stat 1:22, 1987Google Scholar
  24. 24.
    Krieger N: Exposure, susceptibility, and breast cancer risk. Breast Cancer Res Treat 13:205–223, 1989PubMedGoogle Scholar
  25. 25.
    Finklea J, Priester F, Creason JP, et al: Polychlorinated biphenyl residues in human plasma expose a major urban pollution problem. Am J Pub Health 62:645–651, 1972PubMedGoogle Scholar
  26. 26.
    Kutz FW, Yobs AR, Strassman SC: Racial stratification of organochlorine insecticide residues in human adipose tissue. J Occup Med 19:619–622, 1977PubMedGoogle Scholar
  27. 27.
    Michels KB, Hsieh CC, Trichopoulos D, et al: Abortion and breast cancer risk in seven countries. Cancer Causes Control 6(1):75–82, 1995PubMedGoogle Scholar
  28. 28.
    Daling JR, Malone KE, Voigt LF, et al: Risk of breast cancer among young women: Relationship to induced abortion. J Natl Cancer Inst 86:1584–1592, 1994PubMedGoogle Scholar
  29. 29.
    Rosenberg L, Palmer JR, Kaufman DW, et al: Breast cancer in relation to the occurrence and time of induced and spontaneous abortion. Am J Epidemiol 127:981–989, 1988PubMedGoogle Scholar
  30. 30.
    Hadjimichael OC, Boyle CA, Meis J: Abortion before first live birth and risk of breast cancer. Br J Cancer 53:281–284, 1986PubMedGoogle Scholar
  31. 31.
    Pike MC, Henderson BE, Casagrande JT, et al: Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer 43:72–76, 1981PubMedGoogle Scholar
  32. 32.
    Krieger N, Wolff MS, et al: Breast cancer and serum organochlorines: a prospective study among white, black and Asian women. J Natl Cancer Inst 86:589–599, 1994PubMedGoogle Scholar
  33. 33.
    Wolff MS: Occupationally derived chemicals in breast milk. Am J Ind Med 4:259–281, 1983PubMedGoogle Scholar
  34. 34.
    Wolff M, Toniolo PG, Lee EW, et al: Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85:648–652, 1993PubMedGoogle Scholar
  35. 35.
    Ownby HE, Frederick J, Russo J, et al: Racial differences in breast cancer patients. J Natl Cancer Inst 75:55–60, 1985PubMedGoogle Scholar
  36. 36.
    Natarajan, Nachimuthu M, Takuma N, et al: Racerelated differences in breast cancer patients: Results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer 56:1704–1709, 1985PubMedGoogle Scholar
  37. 37.
    Vernon S, Tilley C, et al: Ethnicity, survival and delay in seeking treatment for symptoms of breast cancer. Cancer 55:1563–1571, 1985PubMedGoogle Scholar
  38. 38.
    Dansey RD, Hessel P, Browde S, et al: Lack of a significant independent effect of race on survival in breast cancer. Cancer 61:1908–1912, 1988PubMedGoogle Scholar
  39. 39.
    Gordon N, Joseph C, et al: Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol 135:609–618, 1992PubMedGoogle Scholar
  40. 40.
    Hunter C, Redmond C, et al: Breast cancer: Factors associated with stage at diagnosis in black and white women. J Natl Cancer Inst 85:1129–1137, 1993PubMedGoogle Scholar
  41. 41.
    Williams R, Laing A, et al: Descriptive analysis of breast cancer in African-American women at Howard University Hospital, 1960–1987. J Natl Med Assoc 85:828–834, 1993PubMedGoogle Scholar
  42. 42.
    Eley W, Hill HA, et al: Racial differences in survival from breast cancer: Results of the National Cancer Institute black/white survival study. JAMA 272:947–954, 1994PubMedGoogle Scholar
  43. 43.
    Elledge RM, Clark GM, et al: Tumor biologic factors and breast cancer prognosis among white, hispanic, and black women in the United States. J Natl Cancer Inst 86:705–712, 1994PubMedGoogle Scholar
  44. 44.
    Jones B, Kasl S, et al: Can mammography screening explain the race difference in stage at diagnosis of breast cancer? Cancer 75:2103–2113, 1995PubMedGoogle Scholar
  45. 45.
    Weiss S, Tartter P, et al: Ethnic difference in risk and prognostic factors for breast cancer. Cancer 76: 268–274, 1995PubMedGoogle Scholar
  46. 46.
    Chen VW, Correa P, et al: Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomark Prev 3:127–135, 1994Google Scholar
  47. 47.
    Ansell D, Whitman S, Lipton R, Cooper R: Race income, and survival from breast cancer at two public hospitals. Cancer 72:2974–2978, 1993PubMedGoogle Scholar
  48. 48.
    Muss HB, Hunter CP, Wesley M, et al: Treatment plans for black and white women with stage II nodepositive breast cancer. The National Cancer Institute black/white cancer survival study experience. Cancer 70:2460–2467, 1992PubMedGoogle Scholar
  49. 49.
    Roach M 3rd, Alexander M: The prognostic significance of race and survival from breast cancer: A model for assessing the reliability of reported survival differences. J Natl Med Assoc 87:214–219, 1995PubMedGoogle Scholar
  50. 50.
    Zaloznik A: Breast cancer stage at diagnosis: Caucasians versus Afro-Americans. Breast Cancer Res Treat 34:195–198, 1995PubMedGoogle Scholar
  51. 51.
    Trock B, Rimer BK, et al: Impact of an HMO-based intervention to increase mammography utilization. Cancer Epidemiol Biomark Prev 2:151–156, 1993Google Scholar
  52. 52.
    Kimmick G, Muss H, et al: A comparison of treatment outcomes for black patients and white patients with metastatic breast cancer. Cancer 67:2850–2854, 1991PubMedGoogle Scholar
  53. 53.
    Pierce L, Fowble B, et al: Conservative surgery and radiation therapy in black women with early stage breast cancer. Patterns of failure and analysis of outcome. Cancer 69:2831–2841, 1992PubMedGoogle Scholar
  54. 54.
    Mohla S, Sampson CC, Khan T, et al: Estrogen and progesterone receptors in breast cancer in Black Americans. Cancer 50:552–559, 1982PubMedGoogle Scholar
  55. 55.
    Valanis B, Wirman J, Hertzberg VS: Social and biological factors in relation to survival among black vs. white women with breast cancer. Breast Cancer Res Treat 9:135–143, 1987PubMedGoogle Scholar
  56. 56.
    Kovi J, Mohla S, et al: Breast lesions in black women. Pathol Annu 24:199–218, 1989PubMedGoogle Scholar
  57. 57.
    Shiao YH, Chen VW, Scheer WD, et al: Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res 55:1485–1490, 1995PubMedGoogle Scholar
  58. 58.
    Faust B, Johnson W, et al: Biracial comparisons of breast cancer among New Orleans females.In: Correa P, Johnson WD: An International Survey of Distributions of Histologic Types of Breast Cancers. UICC Technical Report Series 35, Geneva, 1978, pp 101–118Google Scholar
  59. 59.
    Mittra N, Rush BF Jr, Verner E: A comparative study of breast cancer in the black and white populations of two inner city hospitals. J Surg Oncol 15:11–17, 1980PubMedGoogle Scholar
  60. 60.
    Freeman H, Wasfie T: Cancer of the breast in poor black women. Cancer 63:2562–2569, 1989PubMedGoogle Scholar
  61. 61.
    Pegoraro RJ, Nirmul D, Reinach SG, et al: Breast cancer prognosis in three different racial groups in relation to steroid hormone receptor status. Breast Cancer Res Treat 7:111–118, 1986PubMedGoogle Scholar
  62. 62.
    Pegoraro RJ, Karnan V, Nirmul D, et al: Estrogen and progesterone receptors in breast cancer among women of different racial groups. Cancer Res 46: 2117–2120, 1986PubMedGoogle Scholar
  63. 63.
    Beverly LN, Flanders WD, Go RC, et al: A comparison of estrogen and progesterone receptors in black and white breast cancer patients. Am J Pub Health 77:351–353, 1987PubMedGoogle Scholar
  64. 64.
    Stanford J, Greenberg R: Breast cancer incidence in young women by estrogen receptor status and race. Am J Pub Health 79:71–73, 1989PubMedGoogle Scholar
  65. 65.
    Blaszyk H, Vaughn CB, et al: Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer. Lancet 343:1195–1197, 1994PubMedGoogle Scholar
  66. 66.
    Trock BJ: Molecular epidemiology.In: Harris JR, Lippman ME, Morrow M, Hellman S (eds) Diseases of the Breast. JB Lippincott, Philadelphia, 1995, pp 213–220Google Scholar
  67. 67.
    Zambetti GP, Levine AJ: A comparison of the biological activities of wild-type and mutant p53. FASEB J 7:855–865, 1993PubMedGoogle Scholar
  68. 68.
    Dittmer D, Pati S, et al: Gain of function mutations in p53. Nature Genet 4:42–46, 1993PubMedGoogle Scholar
  69. 69.
    Wenger CR, Beardslee S, et al: DNA ploidy, Sphase, and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treat 28: 9–20, 1993PubMedGoogle Scholar
  70. 70.
    Taioli E, Trachman J, et al: A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res 55:3757–3758, 1995PubMedGoogle Scholar
  71. 71.
    Coates RJ, Clark WS, et al: Race, nutritional status, and survival from breast cancer. J Natl Cancer Inst 82:1684–1692, 1990PubMedGoogle Scholar
  72. 72.
    Taioli E, Crofts F, et al: A specific African-American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Res 55:472–473, 1995PubMedGoogle Scholar
  73. 73.
    Evans WE, Relling MV, et al: Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in Black Americans. J Clin Invest 91:2150–2154, 1993PubMedGoogle Scholar
  74. 74.
    Weston A, Ling-Cawley HM, et al: Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis 15: 583–587, 1994PubMedGoogle Scholar
  75. 75.
    Weston A, Vineis P, et al: Racial variation in the distribution of the Ha-ras-1 allele. Mol Carcinogen 4:265–268, 1991Google Scholar
  76. 76.
    Bell DA, Taylor JA, et al: Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 14:1689–1692, 1993PubMedGoogle Scholar
  77. 77.
    Rothman N, Stewart WF, et al: Misclassification of genetic susceptibility biomarkers: implications for case-control studies and cross-population comparisons. Cancer Epidemiol Biomark Prev 2:299–303, 1993Google Scholar
  78. 78.
    Struewing JP, Abeliovich D, et al: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 11:198–200, 1995PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Bruce J. Trock
    • 1
  1. 1.Lombardi Cancer CenterGeorgetown University Medical CenterWashington DCUSA

Personalised recommendations